Despite the prevalence of TP53 mutations in ovarian cancer and the accumulating evidence for gain-of-function cancer-associated TP53 mutations, little is known about the role of p53 mutants in ovarian cancer development and progression. The gene discussed is TP53; the disease is cancer.